Heparin-induced thrombocytopenia (HIT) is a potentially devastating immune mediated
adverse drug reaction caused by the emergence of antibodies that activate platelets in the …

Thrombocytopenia following heparin administration can be associated with an immune
reaction, now referred to as heparin-induced thrombocytopenia. HIT is essentially a …

Thrombocytopenia is a relatively frequent and usually benign clinical complication of
heparin therapy. However, some patients receiving heparin and heparin-based products …

Heparin-induced thrombocytopenia (HIT) is an immune-mediated hypercoagulable disorder
caused by antibodies to platelet factor 4 (PF4) and heparin. HIT develops in temporal …

Heparin-induced thrombocytopenia (HIT) is the most important immunological drug reaction
that patients face today. HIT typically develops in patients 5 days after starting heparin …

Immune heparin-induced thrombocytopenia (HIT) is a relevant adverse drug reaction
consisting in a hypercoagulable state caused by an anticoagulant agent. The incidence is …

Heparin-induced thrombocytopenia (HIT) is a life and limb-threatening complication of
heparin exposure. Here, we review the pathogenesis, incidence, diagnosis, and …

The past decade has seen many important advances in the pathogenesis, clinical and
laboratory diagnosis, and management of heparin-induced thrombocytopenia (HIT), one of …

Heparin-induced thrombocytopenia (HIT) is an adverse prothrombotic disorder caused by
an immune response to complexes of platelet factor 4 and polyanions. The clinical …

Heparin-induced thrombocytopenia (HIT) is a prothrombotic disorder caused by antibodies
that recognize complexes of platelet factor 4 (PF4) and heparin. HIT is frequently considered …